nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—NCOA3—hematologic cancer	0.279	0.728	CbGaD
Amsacrine—NCOA3—Teniposide—hematologic cancer	0.174	0.434	CbGbCtD
Amsacrine—TOP2A—hematologic cancer	0.0811	0.212	CbGaD
Amsacrine—TOP2A—Idarubicin—hematologic cancer	0.0417	0.104	CbGbCtD
Amsacrine—TOP2A—Daunorubicin—hematologic cancer	0.0295	0.0734	CbGbCtD
Amsacrine—TOP2A—Teniposide—hematologic cancer	0.0256	0.0638	CbGbCtD
Amsacrine—ABCB1—hematologic cancer	0.0231	0.0602	CbGaD
Amsacrine—TOP2A—Mitoxantrone—hematologic cancer	0.0179	0.0446	CbGbCtD
Amsacrine—TOP2A—Epirubicin—hematologic cancer	0.0145	0.0361	CbGbCtD
Amsacrine—TOP2A—Etoposide—hematologic cancer	0.0113	0.0281	CbGbCtD
Amsacrine—TOP2A—Doxorubicin—hematologic cancer	0.00771	0.0192	CbGbCtD
Amsacrine—ABCB1—Lenalidomide—hematologic cancer	0.00673	0.0167	CbGbCtD
Amsacrine—CYP2D6—Lomustine—hematologic cancer	0.00589	0.0147	CbGbCtD
Amsacrine—CYP2D6—Idarubicin—hematologic cancer	0.00525	0.0131	CbGbCtD
Amsacrine—CYP2D6—Hydroxyurea—hematologic cancer	0.00447	0.0111	CbGbCtD
Amsacrine—ABCB1—Daunorubicin—hematologic cancer	0.00394	0.00982	CbGbCtD
Amsacrine—CYP2D6—Bortezomib—hematologic cancer	0.00389	0.00967	CbGbCtD
Amsacrine—ABCB1—Alitretinoin—hematologic cancer	0.00386	0.00962	CbGbCtD
Amsacrine—ABCB1—Imatinib—hematologic cancer	0.00302	0.00752	CbGbCtD
Amsacrine—CYP2D6—Imatinib—hematologic cancer	0.00285	0.00709	CbGbCtD
Amsacrine—ABCB1—Nilotinib—hematologic cancer	0.00275	0.00684	CbGbCtD
Amsacrine—ABCB1—Vinorelbine—hematologic cancer	0.00272	0.00678	CbGbCtD
Amsacrine—CYP2D6—Nilotinib—hematologic cancer	0.00259	0.00644	CbGbCtD
Amsacrine—CYP2D6—Vinorelbine—hematologic cancer	0.00257	0.00639	CbGbCtD
Amsacrine—ABCB1—Dasatinib—hematologic cancer	0.00243	0.00604	CbGbCtD
Amsacrine—ABCB1—Mitoxantrone—hematologic cancer	0.0024	0.00597	CbGbCtD
Amsacrine—ABCB1—Betamethasone—hematologic cancer	0.00214	0.00532	CbGbCtD
Amsacrine—ABCB1—Gemcitabine—hematologic cancer	0.00212	0.00527	CbGbCtD
Amsacrine—ABCB1—Prednisolone—hematologic cancer	0.00211	0.00525	CbGbCtD
Amsacrine—ABCB1—Prednisone—hematologic cancer	0.00199	0.00496	CbGbCtD
Amsacrine—NCOA3—hematopoietic system—hematologic cancer	0.00196	0.119	CbGeAlD
Amsacrine—ABCB1—Irinotecan—hematologic cancer	0.00189	0.0047	CbGbCtD
Amsacrine—ABCB1—Vinblastine—hematologic cancer	0.00168	0.00418	CbGbCtD
Amsacrine—ABCB1—Vincristine—hematologic cancer	0.00165	0.00411	CbGbCtD
Amsacrine—CYP2D6—Vinblastine—hematologic cancer	0.00158	0.00394	CbGbCtD
Amsacrine—ABCB1—Cisplatin—hematologic cancer	0.00154	0.00383	CbGbCtD
Amsacrine—ABCB1—Etoposide—hematologic cancer	0.00151	0.00376	CbGbCtD
Amsacrine—NCOA3—gonad—hematologic cancer	0.00149	0.0903	CbGeAlD
Amsacrine—NCOA3—blood—hematologic cancer	0.0013	0.0786	CbGeAlD
Amsacrine—NCOA3—bone marrow—hematologic cancer	0.00125	0.0761	CbGeAlD
Amsacrine—ABCB1—Dexamethasone—hematologic cancer	0.00124	0.00309	CbGbCtD
Amsacrine—CYP2D6—Dexamethasone—hematologic cancer	0.00117	0.00292	CbGbCtD
Amsacrine—NCOA3—lung—hematologic cancer	0.00114	0.0689	CbGeAlD
Amsacrine—NCOA3—testis—hematologic cancer	0.00107	0.0651	CbGeAlD
Amsacrine—ABCB1—Doxorubicin—hematologic cancer	0.00103	0.00257	CbGbCtD
Amsacrine—ABCB1—Methotrexate—hematologic cancer	0.000999	0.00249	CbGbCtD
Amsacrine—CYP2D6—Doxorubicin—hematologic cancer	0.000971	0.00242	CbGbCtD
Amsacrine—NCOA3—lymph node—hematologic cancer	0.000777	0.0472	CbGeAlD
Amsacrine—TOP2A—blood—hematologic cancer	0.00076	0.0461	CbGeAlD
Amsacrine—TOP2A—bone marrow—hematologic cancer	0.000735	0.0446	CbGeAlD
Amsacrine—TOP2A—lung—hematologic cancer	0.000666	0.0404	CbGeAlD
Amsacrine—KCNH2—hematopoietic system—hematologic cancer	0.000643	0.039	CbGeAlD
Amsacrine—TOP2A—testis—hematologic cancer	0.000629	0.0382	CbGeAlD
Amsacrine—NCOA3—Topotecan—Irinotecan—hematologic cancer	0.000468	0.179	CbGdCrCtD
Amsacrine—TOP2A—lymph node—hematologic cancer	0.000456	0.0277	CbGeAlD
Amsacrine—KCNH2—blood—hematologic cancer	0.000426	0.0259	CbGeAlD
Amsacrine—KCNH2—bone marrow—hematologic cancer	0.000412	0.025	CbGeAlD
Amsacrine—CYP2D6—hematopoietic system—hematologic cancer	0.000392	0.0238	CbGeAlD
Amsacrine—KCNH2—testis—hematologic cancer	0.000352	0.0214	CbGeAlD
Amsacrine—NCOA3—Idarubicin—Daunorubicin—hematologic cancer	0.000316	0.121	CbGdCrCtD
Amsacrine—ABCB1—hematopoietic system—hematologic cancer	0.000282	0.0171	CbGeAlD
Amsacrine—CYP2D6—blood—hematologic cancer	0.00026	0.0158	CbGeAlD
Amsacrine—KCNH2—lymph node—hematologic cancer	0.000255	0.0155	CbGeAlD
Amsacrine—CYP2D6—testis—hematologic cancer	0.000215	0.013	CbGeAlD
Amsacrine—ABCB1—gonad—hematologic cancer	0.000214	0.013	CbGeAlD
Amsacrine—ABCB1—blood—hematologic cancer	0.000187	0.0113	CbGeAlD
Amsacrine—ABCB1—bone marrow—hematologic cancer	0.000181	0.011	CbGeAlD
Amsacrine—ABCB1—lung—hematologic cancer	0.000164	0.00994	CbGeAlD
Amsacrine—ABCB1—testis—hematologic cancer	0.000155	0.00938	CbGeAlD
Amsacrine—NCOA3—Gemcitabine—Cytarabine—hematologic cancer	0.000129	0.0494	CbGdCrCtD
Amsacrine—TOP2A—Nilotinib—Imatinib—hematologic cancer	0.000116	0.0443	CbGdCrCtD
Amsacrine—ABCB1—lymph node—hematologic cancer	0.000112	0.0068	CbGeAlD
Amsacrine—NCOA3—Idarubicin—Epirubicin—hematologic cancer	0.00011	0.0421	CbGdCrCtD
Amsacrine—NCOA3—Idarubicin—Doxorubicin—hematologic cancer	0.000102	0.0389	CbGdCrCtD
Amsacrine—TOP2A—Topotecan—Irinotecan—hematologic cancer	6.43e-05	0.0246	CbGdCrCtD
Amsacrine—TOP2A—Etoposide—Teniposide—hematologic cancer	6.39e-05	0.0244	CbGdCrCtD
Amsacrine—TOP2A—Vindesine—Vinorelbine—hematologic cancer	5.75e-05	0.022	CbGdCrCtD
Amsacrine—TOP2A—Podofilox—Teniposide—hematologic cancer	4.88e-05	0.0186	CbGdCrCtD
Amsacrine—TOP2A—Vindesine—Vinblastine—hematologic cancer	4.6e-05	0.0176	CbGdCrCtD
Amsacrine—TOP2A—Vindesine—Vincristine—hematologic cancer	4.6e-05	0.0176	CbGdCrCtD
Amsacrine—TOP2A—Floxuridine—Pentostatin—hematologic cancer	4.43e-05	0.0169	CbGdCrCtD
Amsacrine—TOP2A—Doxorubicin—Daunorubicin—hematologic cancer	4.35e-05	0.0166	CbGdCrCtD
Amsacrine—TOP2A—Idarubicin—Daunorubicin—hematologic cancer	4.35e-05	0.0166	CbGdCrCtD
Amsacrine—TOP2A—Epirubicin—Daunorubicin—hematologic cancer	4.35e-05	0.0166	CbGdCrCtD
Amsacrine—TOP2A—Menadione—Thalidomide—hematologic cancer	3.7e-05	0.0141	CbGdCrCtD
Amsacrine—TOP2A—Cladribine—Pentostatin—hematologic cancer	3.36e-05	0.0128	CbGdCrCtD
Amsacrine—TOP2A—Doxorubicin—Idarubicin—hematologic cancer	3.29e-05	0.0126	CbGdCrCtD
Amsacrine—TOP2A—Daunorubicin—Idarubicin—hematologic cancer	3.29e-05	0.0126	CbGdCrCtD
Amsacrine—TOP2A—Epirubicin—Idarubicin—hematologic cancer	3.29e-05	0.0126	CbGdCrCtD
Amsacrine—TOP2A—Vincristine—Vinorelbine—hematologic cancer	3.1e-05	0.0119	CbGdCrCtD
Amsacrine—TOP2A—Cladribine—Clofarabine—hematologic cancer	2.99e-05	0.0114	CbGdCrCtD
Amsacrine—TOP2A—Vinorelbine—Vincristine—hematologic cancer	2.9e-05	0.0111	CbGdCrCtD
Amsacrine—TOP2A—Vinorelbine—Vinblastine—hematologic cancer	2.9e-05	0.0111	CbGdCrCtD
Amsacrine—TOP2A—Podofilox—Etoposide—hematologic cancer	2.9e-05	0.0111	CbGdCrCtD
Amsacrine—TOP2A—Teniposide—Etoposide—hematologic cancer	2.9e-05	0.0111	CbGdCrCtD
Amsacrine—TOP2A—Cladribine—Nelarabine—hematologic cancer	2.81e-05	0.0107	CbGdCrCtD
Amsacrine—TOP2A—Floxuridine—Cladribine—hematologic cancer	2.67e-05	0.0102	CbGdCrCtD
Amsacrine—TOP2A—Clofarabine—Nelarabine—hematologic cancer	2.6e-05	0.00993	CbGdCrCtD
Amsacrine—TOP2A—Vinblastine—Vinorelbine—hematologic cancer	2.5e-05	0.00954	CbGdCrCtD
Amsacrine—TOP2A—Vincristine—Vinblastine—hematologic cancer	2.48e-05	0.00948	CbGdCrCtD
Amsacrine—TOP2A—Cytarabine—Clofarabine—hematologic cancer	2.35e-05	0.00899	CbGdCrCtD
Amsacrine—TOP2A—Cytarabine—Nelarabine—hematologic cancer	2.21e-05	0.00845	CbGdCrCtD
Amsacrine—TOP2A—Cladribine—Fludarabine—hematologic cancer	2.2e-05	0.00839	CbGdCrCtD
Amsacrine—TOP2A—Clofarabine—Fludarabine—hematologic cancer	2.03e-05	0.00775	CbGdCrCtD
Amsacrine—TOP2A—Vinblastine—Vincristine—hematologic cancer	2e-05	0.00762	CbGdCrCtD
Amsacrine—TOP2A—Clofarabine—Cytarabine—hematologic cancer	1.92e-05	0.00732	CbGdCrCtD
Amsacrine—TOP2A—Azacitidine—Pentostatin—hematologic cancer	1.89e-05	0.00723	CbGdCrCtD
Amsacrine—TOP2A—Clofarabine—Cladribine—hematologic cancer	1.87e-05	0.00714	CbGdCrCtD
Amsacrine—TOP2A—Gemcitabine—Cytarabine—hematologic cancer	1.78e-05	0.00678	CbGdCrCtD
Amsacrine—TOP2A—Cytarabine—Fludarabine—hematologic cancer	1.73e-05	0.0066	CbGdCrCtD
Amsacrine—TOP2A—Azacitidine—Clofarabine—hematologic cancer	1.69e-05	0.00644	CbGdCrCtD
Amsacrine—TOP2A—Cytarabine—Gemcitabine—hematologic cancer	1.63e-05	0.00623	CbGdCrCtD
Amsacrine—TOP2A—Azacitidine—Nelarabine—hematologic cancer	1.59e-05	0.00606	CbGdCrCtD
Amsacrine—TOP2A—Doxorubicin—Epirubicin—hematologic cancer	1.51e-05	0.00578	CbGdCrCtD
Amsacrine—TOP2A—Daunorubicin—Epirubicin—hematologic cancer	1.51e-05	0.00578	CbGdCrCtD
Amsacrine—TOP2A—Idarubicin—Epirubicin—hematologic cancer	1.51e-05	0.00578	CbGdCrCtD
Amsacrine—NCOA3—Metabolism—NCOR1—hematologic cancer	1.47e-05	0.000261	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GSTM1—hematologic cancer	1.47e-05	0.000261	CbGpPWpGaD
Amsacrine—Vomiting—Vincristine—hematologic cancer	1.47e-05	0.000106	CcSEcCtD
Amsacrine—Anorexia—Betamethasone—hematologic cancer	1.47e-05	0.000106	CcSEcCtD
Amsacrine—Anorexia—Dexamethasone—hematologic cancer	1.47e-05	0.000106	CcSEcCtD
Amsacrine—Urticaria—Prednisolone—hematologic cancer	1.47e-05	0.000106	CcSEcCtD
Amsacrine—Asthenia—Cisplatin—hematologic cancer	1.47e-05	0.000106	CcSEcCtD
Amsacrine—Cardiac disorder—Methotrexate—hematologic cancer	1.47e-05	0.000105	CcSEcCtD
Amsacrine—Fatigue—Triamcinolone—hematologic cancer	1.47e-05	0.000105	CcSEcCtD
Amsacrine—Urinary tract disorder—Epirubicin—hematologic cancer	1.46e-05	0.000105	CcSEcCtD
Amsacrine—Rash—Vincristine—hematologic cancer	1.46e-05	0.000105	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.46e-05	0.000258	CbGpPWpGaD
Amsacrine—Dermatitis—Vincristine—hematologic cancer	1.46e-05	0.000105	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—hematologic cancer	1.46e-05	0.000258	CbGpPWpGaD
Amsacrine—Pain—Triamcinolone—hematologic cancer	1.46e-05	0.000105	CcSEcCtD
Amsacrine—Haematuria—Doxorubicin—hematologic cancer	1.46e-05	0.000104	CcSEcCtD
Amsacrine—Connective tissue disorder—Epirubicin—hematologic cancer	1.46e-05	0.000104	CcSEcCtD
Amsacrine—Urethral disorder—Epirubicin—hematologic cancer	1.45e-05	0.000104	CcSEcCtD
Amsacrine—Headache—Vincristine—hematologic cancer	1.45e-05	0.000104	CcSEcCtD
Amsacrine—KCNH2—Neuronal System—MDM2—hematologic cancer	1.45e-05	0.000257	CbGpPWpGaD
Amsacrine—Hepatobiliary disease—Doxorubicin—hematologic cancer	1.44e-05	0.000104	CcSEcCtD
Amsacrine—Hypotension—Betamethasone—hematologic cancer	1.44e-05	0.000104	CcSEcCtD
Amsacrine—Hypotension—Dexamethasone—hematologic cancer	1.44e-05	0.000104	CcSEcCtD
Amsacrine—Nausea—Carmustine—hematologic cancer	1.44e-05	0.000104	CcSEcCtD
Amsacrine—Angiopathy—Methotrexate—hematologic cancer	1.44e-05	0.000103	CcSEcCtD
Amsacrine—Vomiting—Irinotecan—hematologic cancer	1.43e-05	0.000103	CcSEcCtD
Amsacrine—Vomiting—Mitoxantrone—hematologic cancer	1.43e-05	0.000103	CcSEcCtD
Amsacrine—Nausea—Alitretinoin—hematologic cancer	1.43e-05	0.000103	CcSEcCtD
Amsacrine—Convulsion—Prednisone—hematologic cancer	1.43e-05	0.000103	CcSEcCtD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	1.43e-05	0.000253	CbGpPWpGaD
Amsacrine—Mediastinal disorder—Methotrexate—hematologic cancer	1.43e-05	0.000102	CcSEcCtD
Amsacrine—Agranulocytosis—Doxorubicin—hematologic cancer	1.42e-05	0.000102	CcSEcCtD
Amsacrine—Rash—Mitoxantrone—hematologic cancer	1.42e-05	0.000102	CcSEcCtD
Amsacrine—Rash—Irinotecan—hematologic cancer	1.42e-05	0.000102	CcSEcCtD
Amsacrine—Dermatitis—Mitoxantrone—hematologic cancer	1.42e-05	0.000102	CcSEcCtD
Amsacrine—Dermatitis—Irinotecan—hematologic cancer	1.42e-05	0.000102	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.42e-05	0.000251	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.42e-05	0.000251	CbGpPWpGaD
Amsacrine—Headache—Irinotecan—hematologic cancer	1.41e-05	0.000101	CcSEcCtD
Amsacrine—Headache—Mitoxantrone—hematologic cancer	1.41e-05	0.000101	CcSEcCtD
Amsacrine—Nausea—Ifosfamide—hematologic cancer	1.41e-05	0.000101	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—TNF—hematologic cancer	1.41e-05	0.00025	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDK2—hematologic cancer	1.4e-05	0.000249	CbGpPWpGaD
Amsacrine—Feeling abnormal—Triamcinolone—hematologic cancer	1.4e-05	0.000101	CcSEcCtD
Amsacrine—Diarrhoea—Cisplatin—hematologic cancer	1.4e-05	0.000101	CcSEcCtD
Amsacrine—TOP2A—Daunorubicin—Doxorubicin—hematologic cancer	1.4e-05	0.00535	CbGdCrCtD
Amsacrine—TOP2A—Idarubicin—Doxorubicin—hematologic cancer	1.4e-05	0.00535	CbGdCrCtD
Amsacrine—TOP2A—Epirubicin—Doxorubicin—hematologic cancer	1.4e-05	0.00535	CbGdCrCtD
Amsacrine—NCOA3—Developmental Biology—KRAS—hematologic cancer	1.4e-05	0.000248	CbGpPWpGaD
Amsacrine—Alopecia—Methotrexate—hematologic cancer	1.4e-05	0.0001	CcSEcCtD
Amsacrine—Vomiting—Gemcitabine—hematologic cancer	1.4e-05	0.0001	CcSEcCtD
Amsacrine—Bradycardia—Doxorubicin—hematologic cancer	1.39e-05	0.0001	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	1.39e-05	0.0001	CcSEcCtD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—hematologic cancer	1.39e-05	0.000246	CbGpPWpGaD
Amsacrine—Paraesthesia—Dexamethasone—hematologic cancer	1.39e-05	9.96e-05	CcSEcCtD
Amsacrine—Paraesthesia—Betamethasone—hematologic cancer	1.39e-05	9.96e-05	CcSEcCtD
Amsacrine—Mental disorder—Methotrexate—hematologic cancer	1.39e-05	9.95e-05	CcSEcCtD
Amsacrine—Rash—Gemcitabine—hematologic cancer	1.39e-05	9.95e-05	CcSEcCtD
Amsacrine—Dermatitis—Gemcitabine—hematologic cancer	1.38e-05	9.94e-05	CcSEcCtD
Amsacrine—Hypersensitivity—Etoposide—hematologic cancer	1.38e-05	9.93e-05	CcSEcCtD
Amsacrine—Malnutrition—Methotrexate—hematologic cancer	1.38e-05	9.89e-05	CcSEcCtD
Amsacrine—Haemoglobin—Doxorubicin—hematologic cancer	1.38e-05	9.89e-05	CcSEcCtD
Amsacrine—Headache—Gemcitabine—hematologic cancer	1.38e-05	9.89e-05	CcSEcCtD
Amsacrine—Nausea—Vincristine—hematologic cancer	1.38e-05	9.88e-05	CcSEcCtD
Amsacrine—Cardiac disorder—Epirubicin—hematologic cancer	1.37e-05	9.87e-05	CcSEcCtD
Amsacrine—Haemorrhage—Doxorubicin—hematologic cancer	1.37e-05	9.84e-05	CcSEcCtD
Amsacrine—Hepatitis—Doxorubicin—hematologic cancer	1.37e-05	9.84e-05	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—BIRC5—hematologic cancer	1.37e-05	0.000242	CbGpPWpGaD
Amsacrine—Hypersensitivity—Prednisolone—hematologic cancer	1.36e-05	9.79e-05	CcSEcCtD
Amsacrine—ABCB1—Allograft Rejection—IFNG—hematologic cancer	1.36e-05	0.000241	CbGpPWpGaD
Amsacrine—Hypoaesthesia—Doxorubicin—hematologic cancer	1.36e-05	9.79e-05	CcSEcCtD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—JUN—hematologic cancer	1.36e-05	0.000241	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—STAT1—hematologic cancer	1.35e-05	0.00024	CbGpPWpGaD
Amsacrine—Urinary tract disorder—Doxorubicin—hematologic cancer	1.35e-05	9.72e-05	CcSEcCtD
Amsacrine—Urticaria—Triamcinolone—hematologic cancer	1.35e-05	9.71e-05	CcSEcCtD
Amsacrine—Asthenia—Etoposide—hematologic cancer	1.35e-05	9.67e-05	CcSEcCtD
Amsacrine—Connective tissue disorder—Doxorubicin—hematologic cancer	1.35e-05	9.67e-05	CcSEcCtD
Amsacrine—Body temperature increased—Triamcinolone—hematologic cancer	1.35e-05	9.66e-05	CcSEcCtD
Amsacrine—Angiopathy—Epirubicin—hematologic cancer	1.34e-05	9.65e-05	CcSEcCtD
Amsacrine—Urethral disorder—Doxorubicin—hematologic cancer	1.34e-05	9.64e-05	CcSEcCtD
Amsacrine—Decreased appetite—Dexamethasone—hematologic cancer	1.34e-05	9.64e-05	CcSEcCtD
Amsacrine—Decreased appetite—Betamethasone—hematologic cancer	1.34e-05	9.64e-05	CcSEcCtD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	1.34e-05	0.000238	CbGpPWpGaD
Amsacrine—Nausea—Mitoxantrone—hematologic cancer	1.34e-05	9.62e-05	CcSEcCtD
Amsacrine—Nausea—Irinotecan—hematologic cancer	1.34e-05	9.62e-05	CcSEcCtD
Amsacrine—Infection—Prednisone—hematologic cancer	1.34e-05	9.6e-05	CcSEcCtD
Amsacrine—Mediastinal disorder—Epirubicin—hematologic cancer	1.33e-05	9.58e-05	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.33e-05	9.58e-05	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.33e-05	9.58e-05	CcSEcCtD
Amsacrine—Fatigue—Betamethasone—hematologic cancer	1.33e-05	9.56e-05	CcSEcCtD
Amsacrine—Fatigue—Dexamethasone—hematologic cancer	1.33e-05	9.56e-05	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDK4—hematologic cancer	1.33e-05	0.000235	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TERT—hematologic cancer	1.33e-05	0.000235	CbGpPWpGaD
Amsacrine—Arrhythmia—Epirubicin—hematologic cancer	1.32e-05	9.5e-05	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.32e-05	0.000234	CbGpPWpGaD
Amsacrine—Pain—Dexamethasone—hematologic cancer	1.32e-05	9.48e-05	CcSEcCtD
Amsacrine—Pain—Betamethasone—hematologic cancer	1.32e-05	9.48e-05	CcSEcCtD
Amsacrine—Tachycardia—Prednisone—hematologic cancer	1.31e-05	9.43e-05	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.31e-05	0.000232	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—AR—hematologic cancer	1.31e-05	0.000232	CbGpPWpGaD
Amsacrine—Alopecia—Epirubicin—hematologic cancer	1.31e-05	9.4e-05	CcSEcCtD
Amsacrine—Skin disorder—Prednisone—hematologic cancer	1.31e-05	9.38e-05	CcSEcCtD
Amsacrine—Nausea—Gemcitabine—hematologic cancer	1.31e-05	9.37e-05	CcSEcCtD
Amsacrine—NCOA3—Metabolism—MTHFR—hematologic cancer	1.3e-05	0.000231	CbGpPWpGaD
Amsacrine—Vomiting—Cisplatin—hematologic cancer	1.3e-05	9.35e-05	CcSEcCtD
Amsacrine—Vision blurred—Methotrexate—hematologic cancer	1.3e-05	9.32e-05	CcSEcCtD
Amsacrine—Mental disorder—Epirubicin—hematologic cancer	1.3e-05	9.32e-05	CcSEcCtD
Amsacrine—Rash—Cisplatin—hematologic cancer	1.29e-05	9.27e-05	CcSEcCtD
Amsacrine—Dermatitis—Cisplatin—hematologic cancer	1.29e-05	9.27e-05	CcSEcCtD
Amsacrine—Malnutrition—Epirubicin—hematologic cancer	1.29e-05	9.26e-05	CcSEcCtD
Amsacrine—Diarrhoea—Etoposide—hematologic cancer	1.28e-05	9.22e-05	CcSEcCtD
Amsacrine—Anorexia—Prednisone—hematologic cancer	1.28e-05	9.21e-05	CcSEcCtD
Amsacrine—CYP2D6—Biological oxidations—GSTP1—hematologic cancer	1.28e-05	0.000226	CbGpPWpGaD
Amsacrine—Anaemia—Methotrexate—hematologic cancer	1.27e-05	9.14e-05	CcSEcCtD
Amsacrine—Feeling abnormal—Betamethasone—hematologic cancer	1.27e-05	9.14e-05	CcSEcCtD
Amsacrine—Feeling abnormal—Dexamethasone—hematologic cancer	1.27e-05	9.14e-05	CcSEcCtD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	1.27e-05	0.000225	CbGpPWpGaD
Amsacrine—Cardiac disorder—Doxorubicin—hematologic cancer	1.27e-05	9.13e-05	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—GRB2—hematologic cancer	1.27e-05	0.000224	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—hematologic cancer	1.26e-05	0.000224	CbGpPWpGaD
Amsacrine—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.26e-05	9.07e-05	CcSEcCtD
Amsacrine—Gastrointestinal pain—Betamethasone—hematologic cancer	1.26e-05	9.07e-05	CcSEcCtD
Amsacrine—CYP2D6—Metapathway biotransformation—GSTP1—hematologic cancer	1.26e-05	0.000223	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDK2—hematologic cancer	1.26e-05	0.000222	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—EP300—hematologic cancer	1.26e-05	0.000222	CbGpPWpGaD
Amsacrine—Hypersensitivity—Triamcinolone—hematologic cancer	1.25e-05	9.01e-05	CcSEcCtD
Amsacrine—Angiopathy—Doxorubicin—hematologic cancer	1.24e-05	8.93e-05	CcSEcCtD
Amsacrine—Dizziness—Etoposide—hematologic cancer	1.24e-05	8.91e-05	CcSEcCtD
Amsacrine—TOP2A—Azacitidine—Fludarabine—hematologic cancer	1.24e-05	0.00473	CbGdCrCtD
Amsacrine—Mediastinal disorder—Doxorubicin—hematologic cancer	1.23e-05	8.87e-05	CcSEcCtD
Amsacrine—Leukopenia—Methotrexate—hematologic cancer	1.23e-05	8.85e-05	CcSEcCtD
Amsacrine—Urticaria—Dexamethasone—hematologic cancer	1.23e-05	8.81e-05	CcSEcCtD
Amsacrine—Urticaria—Betamethasone—hematologic cancer	1.23e-05	8.81e-05	CcSEcCtD
Amsacrine—Dizziness—Prednisolone—hematologic cancer	1.22e-05	8.79e-05	CcSEcCtD
Amsacrine—Arrhythmia—Doxorubicin—hematologic cancer	1.22e-05	8.79e-05	CcSEcCtD
Amsacrine—Asthenia—Triamcinolone—hematologic cancer	1.22e-05	8.77e-05	CcSEcCtD
Amsacrine—Body temperature increased—Betamethasone—hematologic cancer	1.22e-05	8.77e-05	CcSEcCtD
Amsacrine—Abdominal pain—Dexamethasone—hematologic cancer	1.22e-05	8.77e-05	CcSEcCtD
Amsacrine—Abdominal pain—Betamethasone—hematologic cancer	1.22e-05	8.77e-05	CcSEcCtD
Amsacrine—Body temperature increased—Dexamethasone—hematologic cancer	1.22e-05	8.77e-05	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—hematologic cancer	1.22e-05	0.000215	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—hematologic cancer	1.22e-05	0.000215	CbGpPWpGaD
Amsacrine—Nausea—Cisplatin—hematologic cancer	1.22e-05	8.74e-05	CcSEcCtD
Amsacrine—ABCB1—Allograft Rejection—IL1B—hematologic cancer	1.22e-05	0.000215	CbGpPWpGaD
Amsacrine—Vision blurred—Epirubicin—hematologic cancer	1.21e-05	8.72e-05	CcSEcCtD
Amsacrine—ABCB1—Allograft Rejection—CASP3—hematologic cancer	1.21e-05	0.000215	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—IL6—hematologic cancer	1.21e-05	0.000215	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—IL2—hematologic cancer	1.21e-05	0.000214	CbGpPWpGaD
Amsacrine—Alopecia—Doxorubicin—hematologic cancer	1.21e-05	8.69e-05	CcSEcCtD
Amsacrine—Paraesthesia—Prednisone—hematologic cancer	1.21e-05	8.67e-05	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—hematologic cancer	1.21e-05	0.000214	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.21e-05	0.000213	CbGpPWpGaD
Amsacrine—Mental disorder—Doxorubicin—hematologic cancer	1.2e-05	8.62e-05	CcSEcCtD
Amsacrine—Convulsion—Methotrexate—hematologic cancer	1.19e-05	8.57e-05	CcSEcCtD
Amsacrine—Vomiting—Etoposide—hematologic cancer	1.19e-05	8.57e-05	CcSEcCtD
Amsacrine—Malnutrition—Doxorubicin—hematologic cancer	1.19e-05	8.56e-05	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—ATM—hematologic cancer	1.19e-05	0.000211	CbGpPWpGaD
Amsacrine—Anaemia—Epirubicin—hematologic cancer	1.19e-05	8.55e-05	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—HRAS—hematologic cancer	1.19e-05	0.000211	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—hematologic cancer	1.19e-05	0.00021	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDK4—hematologic cancer	1.19e-05	0.00021	CbGpPWpGaD
Amsacrine—Rash—Etoposide—hematologic cancer	1.18e-05	8.5e-05	CcSEcCtD
Amsacrine—Dermatitis—Etoposide—hematologic cancer	1.18e-05	8.49e-05	CcSEcCtD
Amsacrine—Headache—Etoposide—hematologic cancer	1.18e-05	8.44e-05	CcSEcCtD
Amsacrine—CYP2D6—Biological oxidations—GSTM1—hematologic cancer	1.17e-05	0.000208	CbGpPWpGaD
Amsacrine—Decreased appetite—Prednisone—hematologic cancer	1.17e-05	8.4e-05	CcSEcCtD
Amsacrine—TOP2A—Azacitidine—Cytarabine—hematologic cancer	1.17e-05	0.00447	CbGdCrCtD
Amsacrine—TOP2A—Azacitidine—Gemcitabine—hematologic cancer	1.17e-05	0.00447	CbGdCrCtD
Amsacrine—Rash—Prednisolone—hematologic cancer	1.17e-05	8.38e-05	CcSEcCtD
Amsacrine—Dermatitis—Prednisolone—hematologic cancer	1.17e-05	8.37e-05	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.17e-05	0.000206	CbGpPWpGaD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.16e-05	8.36e-05	CcSEcCtD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SGK1—hematologic cancer	1.16e-05	0.000206	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	1.16e-05	0.000206	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	1.16e-05	0.000206	CbGpPWpGaD
Amsacrine—Fatigue—Prednisone—hematologic cancer	1.16e-05	8.33e-05	CcSEcCtD
Amsacrine—Headache—Prednisolone—hematologic cancer	1.16e-05	8.33e-05	CcSEcCtD
Amsacrine—CYP2D6—Metapathway biotransformation—GSTM1—hematologic cancer	1.16e-05	0.000205	CbGpPWpGaD
Amsacrine—Leukopenia—Epirubicin—hematologic cancer	1.15e-05	8.29e-05	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle, Mitotic—RB1—hematologic cancer	1.15e-05	0.000204	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.15e-05	0.000203	CbGpPWpGaD
Amsacrine—TOP2A—Azacitidine—Cladribine—hematologic cancer	1.14e-05	0.00435	CbGdCrCtD
Amsacrine—NCOA3—Developmental Biology—IL6—hematologic cancer	1.14e-05	0.000202	CbGpPWpGaD
Amsacrine—Confusional state—Methotrexate—hematologic cancer	1.13e-05	8.14e-05	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	1.13e-05	0.0002	CbGpPWpGaD
Amsacrine—Dizziness—Triamcinolone—hematologic cancer	1.13e-05	8.08e-05	CcSEcCtD
Amsacrine—Vision blurred—Doxorubicin—hematologic cancer	1.12e-05	8.07e-05	CcSEcCtD
Amsacrine—TOP2A—Circadian rythm related genes—TP53—hematologic cancer	1.12e-05	0.000198	CbGpPWpGaD
Amsacrine—Convulsion—Epirubicin—hematologic cancer	1.12e-05	8.02e-05	CcSEcCtD
Amsacrine—Infection—Methotrexate—hematologic cancer	1.12e-05	8.02e-05	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	1.12e-05	0.000197	CbGpPWpGaD
Amsacrine—Nausea—Etoposide—hematologic cancer	1.11e-05	8e-05	CcSEcCtD
Amsacrine—Feeling abnormal—Prednisone—hematologic cancer	1.11e-05	7.96e-05	CcSEcCtD
Amsacrine—Asthenia—Betamethasone—hematologic cancer	1.11e-05	7.96e-05	CcSEcCtD
Amsacrine—Asthenia—Dexamethasone—hematologic cancer	1.11e-05	7.96e-05	CcSEcCtD
Amsacrine—Anaemia—Doxorubicin—hematologic cancer	1.1e-05	7.92e-05	CcSEcCtD
Amsacrine—Thrombocytopenia—Methotrexate—hematologic cancer	1.1e-05	7.9e-05	CcSEcCtD
Amsacrine—Gastrointestinal pain—Prednisone—hematologic cancer	1.1e-05	7.9e-05	CcSEcCtD
Amsacrine—Nausea—Prednisolone—hematologic cancer	1.1e-05	7.9e-05	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	1.1e-05	0.000194	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CG—hematologic cancer	1.09e-05	0.000194	CbGpPWpGaD
Amsacrine—Skin disorder—Methotrexate—hematologic cancer	1.09e-05	7.84e-05	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.09e-05	7.83e-05	CcSEcCtD
Amsacrine—Vomiting—Triamcinolone—hematologic cancer	1.08e-05	7.77e-05	CcSEcCtD
Amsacrine—Rash—Triamcinolone—hematologic cancer	1.07e-05	7.71e-05	CcSEcCtD
Amsacrine—Dermatitis—Triamcinolone—hematologic cancer	1.07e-05	7.7e-05	CcSEcCtD
Amsacrine—Anorexia—Methotrexate—hematologic cancer	1.07e-05	7.69e-05	CcSEcCtD
Amsacrine—Urticaria—Prednisone—hematologic cancer	1.07e-05	7.67e-05	CcSEcCtD
Amsacrine—Leukopenia—Doxorubicin—hematologic cancer	1.07e-05	7.67e-05	CcSEcCtD
Amsacrine—Headache—Triamcinolone—hematologic cancer	1.07e-05	7.66e-05	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	1.06e-05	0.000188	CbGpPWpGaD
Amsacrine—Abdominal pain—Prednisone—hematologic cancer	1.06e-05	7.64e-05	CcSEcCtD
Amsacrine—Body temperature increased—Prednisone—hematologic cancer	1.06e-05	7.64e-05	CcSEcCtD
Amsacrine—Confusional state—Epirubicin—hematologic cancer	1.06e-05	7.62e-05	CcSEcCtD
Amsacrine—Diarrhoea—Betamethasone—hematologic cancer	1.06e-05	7.59e-05	CcSEcCtD
Amsacrine—Diarrhoea—Dexamethasone—hematologic cancer	1.06e-05	7.59e-05	CcSEcCtD
Amsacrine—Hypotension—Methotrexate—hematologic cancer	1.05e-05	7.54e-05	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—AKT1—hematologic cancer	1.05e-05	0.000186	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	1.05e-05	0.000185	CbGpPWpGaD
Amsacrine—Infection—Epirubicin—hematologic cancer	1.05e-05	7.5e-05	CcSEcCtD
Amsacrine—ABCB1—Metabolism—GMPS—hematologic cancer	1.04e-05	0.000184	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—FTCD—hematologic cancer	1.04e-05	0.000184	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PHYH—hematologic cancer	1.04e-05	0.000184	CbGpPWpGaD
Amsacrine—Convulsion—Doxorubicin—hematologic cancer	1.03e-05	7.42e-05	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—RB1—hematologic cancer	1.03e-05	0.000183	CbGpPWpGaD
Amsacrine—Thrombocytopenia—Epirubicin—hematologic cancer	1.03e-05	7.4e-05	CcSEcCtD
Amsacrine—ABCB1—Allograft Rejection—VEGFA—hematologic cancer	1.03e-05	0.000182	CbGpPWpGaD
Amsacrine—Tachycardia—Epirubicin—hematologic cancer	1.03e-05	7.37e-05	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	1.03e-05	0.000182	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—IL6—hematologic cancer	1.02e-05	0.000181	CbGpPWpGaD
Amsacrine—Skin disorder—Epirubicin—hematologic cancer	1.02e-05	7.34e-05	CcSEcCtD
Amsacrine—Dizziness—Dexamethasone—hematologic cancer	1.02e-05	7.33e-05	CcSEcCtD
Amsacrine—Dizziness—Betamethasone—hematologic cancer	1.02e-05	7.33e-05	CcSEcCtD
Amsacrine—NCOA3—Metabolism—CREBBP—hematologic cancer	1.01e-05	0.00018	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	1.01e-05	0.00018	CbGpPWpGaD
Amsacrine—Nausea—Triamcinolone—hematologic cancer	1.01e-05	7.26e-05	CcSEcCtD
Amsacrine—Paraesthesia—Methotrexate—hematologic cancer	1.01e-05	7.25e-05	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.01e-05	7.24e-05	CcSEcCtD
Amsacrine—Anorexia—Epirubicin—hematologic cancer	1e-05	7.2e-05	CcSEcCtD
Amsacrine—Dyspnoea—Methotrexate—hematologic cancer	1e-05	7.2e-05	CcSEcCtD
Amsacrine—Hypersensitivity—Prednisone—hematologic cancer	9.91e-06	7.12e-05	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	9.85e-06	0.000174	CbGpPWpGaD
Amsacrine—Hypotension—Epirubicin—hematologic cancer	9.83e-06	7.06e-05	CcSEcCtD
Amsacrine—Vomiting—Betamethasone—hematologic cancer	9.82e-06	7.05e-05	CcSEcCtD
Amsacrine—Vomiting—Dexamethasone—hematologic cancer	9.82e-06	7.05e-05	CcSEcCtD
Amsacrine—Confusional state—Doxorubicin—hematologic cancer	9.82e-06	7.05e-05	CcSEcCtD
Amsacrine—CYP2D6—Metabolism—GMPS—hematologic cancer	9.78e-06	0.000173	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—FTCD—hematologic cancer	9.78e-06	0.000173	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PHYH—hematologic cancer	9.78e-06	0.000173	CbGpPWpGaD
Amsacrine—Decreased appetite—Methotrexate—hematologic cancer	9.77e-06	7.02e-05	CcSEcCtD
Amsacrine—Rash—Betamethasone—hematologic cancer	9.74e-06	6.99e-05	CcSEcCtD
Amsacrine—Rash—Dexamethasone—hematologic cancer	9.74e-06	6.99e-05	CcSEcCtD
Amsacrine—Dermatitis—Betamethasone—hematologic cancer	9.73e-06	6.99e-05	CcSEcCtD
Amsacrine—Dermatitis—Dexamethasone—hematologic cancer	9.73e-06	6.99e-05	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Methotrexate—hematologic cancer	9.71e-06	6.97e-05	CcSEcCtD
Amsacrine—Fatigue—Methotrexate—hematologic cancer	9.69e-06	6.96e-05	CcSEcCtD
Amsacrine—Headache—Betamethasone—hematologic cancer	9.68e-06	6.95e-05	CcSEcCtD
Amsacrine—Headache—Dexamethasone—hematologic cancer	9.68e-06	6.95e-05	CcSEcCtD
Amsacrine—Infection—Doxorubicin—hematologic cancer	9.67e-06	6.94e-05	CcSEcCtD
Amsacrine—Asthenia—Prednisone—hematologic cancer	9.65e-06	6.93e-05	CcSEcCtD
Amsacrine—NCOA3—Metabolism—PIK3CD—hematologic cancer	9.62e-06	0.00017	CbGpPWpGaD
Amsacrine—Pain—Methotrexate—hematologic cancer	9.61e-06	6.9e-05	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	9.55e-06	0.000169	CbGpPWpGaD
Amsacrine—Thrombocytopenia—Doxorubicin—hematologic cancer	9.53e-06	6.84e-05	CcSEcCtD
Amsacrine—Tachycardia—Doxorubicin—hematologic cancer	9.5e-06	6.82e-05	CcSEcCtD
Amsacrine—NCOA3—Metabolism—ALB—hematologic cancer	9.5e-06	0.000168	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SMPD3—hematologic cancer	9.49e-06	0.000168	CbGpPWpGaD
Amsacrine—Skin disorder—Doxorubicin—hematologic cancer	9.46e-06	6.79e-05	CcSEcCtD
Amsacrine—ABCB1—Allograft Rejection—TGFB1—hematologic cancer	9.45e-06	0.000167	CbGpPWpGaD
Amsacrine—Paraesthesia—Epirubicin—hematologic cancer	9.45e-06	6.78e-05	CcSEcCtD
Amsacrine—Dyspnoea—Epirubicin—hematologic cancer	9.38e-06	6.73e-05	CcSEcCtD
Amsacrine—Anorexia—Doxorubicin—hematologic cancer	9.28e-06	6.66e-05	CcSEcCtD
Amsacrine—Feeling abnormal—Methotrexate—hematologic cancer	9.26e-06	6.65e-05	CcSEcCtD
Amsacrine—Diarrhoea—Prednisone—hematologic cancer	9.2e-06	6.61e-05	CcSEcCtD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	9.2e-06	0.000163	CbGpPWpGaD
Amsacrine—Gastrointestinal pain—Methotrexate—hematologic cancer	9.19e-06	6.6e-05	CcSEcCtD
Amsacrine—Nausea—Dexamethasone—hematologic cancer	9.18e-06	6.59e-05	CcSEcCtD
Amsacrine—Nausea—Betamethasone—hematologic cancer	9.18e-06	6.59e-05	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	9.16e-06	0.000162	CbGpPWpGaD
Amsacrine—Decreased appetite—Epirubicin—hematologic cancer	9.15e-06	6.57e-05	CcSEcCtD
Amsacrine—Hypotension—Doxorubicin—hematologic cancer	9.1e-06	6.53e-05	CcSEcCtD
Amsacrine—NCOA3—Metabolism—PIK3R1—hematologic cancer	9.09e-06	0.000161	CbGpPWpGaD
Amsacrine—Gastrointestinal disorder—Epirubicin—hematologic cancer	9.08e-06	6.52e-05	CcSEcCtD
Amsacrine—Fatigue—Epirubicin—hematologic cancer	9.07e-06	6.51e-05	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—CDKN2A—hematologic cancer	9.07e-06	0.000161	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	9.06e-06	0.00016	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	9.03e-06	0.00016	CbGpPWpGaD
Amsacrine—Pain—Epirubicin—hematologic cancer	9e-06	6.46e-05	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	8.99e-06	0.000159	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	8.98e-06	0.000159	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SMPD3—hematologic cancer	8.94e-06	0.000158	CbGpPWpGaD
Amsacrine—Urticaria—Methotrexate—hematologic cancer	8.93e-06	6.41e-05	CcSEcCtD
Amsacrine—Dizziness—Prednisone—hematologic cancer	8.9e-06	6.39e-05	CcSEcCtD
Amsacrine—Abdominal pain—Methotrexate—hematologic cancer	8.89e-06	6.38e-05	CcSEcCtD
Amsacrine—Body temperature increased—Methotrexate—hematologic cancer	8.89e-06	6.38e-05	CcSEcCtD
Amsacrine—ABCB1—Allograft Rejection—TNF—hematologic cancer	8.82e-06	0.000156	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MDM2—hematologic cancer	8.8e-06	0.000156	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	8.77e-06	0.000155	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	8.77e-06	0.000155	CbGpPWpGaD
Amsacrine—Paraesthesia—Doxorubicin—hematologic cancer	8.74e-06	6.28e-05	CcSEcCtD
Amsacrine—Dyspnoea—Doxorubicin—hematologic cancer	8.68e-06	6.23e-05	CcSEcCtD
Amsacrine—Feeling abnormal—Epirubicin—hematologic cancer	8.67e-06	6.22e-05	CcSEcCtD
Amsacrine—Gastrointestinal pain—Epirubicin—hematologic cancer	8.6e-06	6.18e-05	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CCND1—hematologic cancer	8.57e-06	0.000152	CbGpPWpGaD
Amsacrine—Vomiting—Prednisone—hematologic cancer	8.55e-06	6.14e-05	CcSEcCtD
Amsacrine—Rash—Prednisone—hematologic cancer	8.48e-06	6.09e-05	CcSEcCtD
Amsacrine—Dermatitis—Prednisone—hematologic cancer	8.47e-06	6.08e-05	CcSEcCtD
Amsacrine—Decreased appetite—Doxorubicin—hematologic cancer	8.46e-06	6.08e-05	CcSEcCtD
Amsacrine—Headache—Prednisone—hematologic cancer	8.43e-06	6.05e-05	CcSEcCtD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	8.41e-06	0.000149	CbGpPWpGaD
Amsacrine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	8.4e-06	6.03e-05	CcSEcCtD
Amsacrine—Fatigue—Doxorubicin—hematologic cancer	8.39e-06	6.03e-05	CcSEcCtD
Amsacrine—NCOA3—Metabolism—PIK3CB—hematologic cancer	8.39e-06	0.000148	CbGpPWpGaD
Amsacrine—Urticaria—Epirubicin—hematologic cancer	8.36e-06	6e-05	CcSEcCtD
Amsacrine—Pain—Doxorubicin—hematologic cancer	8.33e-06	5.98e-05	CcSEcCtD
Amsacrine—Body temperature increased—Epirubicin—hematologic cancer	8.32e-06	5.97e-05	CcSEcCtD
Amsacrine—Abdominal pain—Epirubicin—hematologic cancer	8.32e-06	5.97e-05	CcSEcCtD
Amsacrine—ABCB1—Metabolism—DCK—hematologic cancer	8.29e-06	0.000147	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—B3GAT1—hematologic cancer	8.29e-06	0.000147	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ASNS—hematologic cancer	8.29e-06	0.000147	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	8.29e-06	0.000147	CbGpPWpGaD
Amsacrine—Hypersensitivity—Methotrexate—hematologic cancer	8.28e-06	5.95e-05	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	8.09e-06	0.000143	CbGpPWpGaD
Amsacrine—Asthenia—Methotrexate—hematologic cancer	8.07e-06	5.79e-05	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—CDKN1B—hematologic cancer	8.03e-06	0.000142	CbGpPWpGaD
Amsacrine—Feeling abnormal—Doxorubicin—hematologic cancer	8.02e-06	5.76e-05	CcSEcCtD
Amsacrine—Nausea—Prednisone—hematologic cancer	7.99e-06	5.74e-05	CcSEcCtD
Amsacrine—Gastrointestinal pain—Doxorubicin—hematologic cancer	7.96e-06	5.72e-05	CcSEcCtD
Amsacrine—KCNH2—Neuronal System—HRAS—hematologic cancer	7.95e-06	0.000141	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—NUP98—hematologic cancer	7.94e-06	0.000141	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	7.91e-06	0.00014	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—EP300—hematologic cancer	7.89e-06	0.00014	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	7.88e-06	0.000139	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HDC—hematologic cancer	7.86e-06	0.000139	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—DCK—hematologic cancer	7.82e-06	0.000138	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—B3GAT1—hematologic cancer	7.82e-06	0.000138	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ASNS—hematologic cancer	7.82e-06	0.000138	CbGpPWpGaD
Amsacrine—Hypersensitivity—Epirubicin—hematologic cancer	7.75e-06	5.57e-05	CcSEcCtD
Amsacrine—Urticaria—Doxorubicin—hematologic cancer	7.73e-06	5.55e-05	CcSEcCtD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	7.71e-06	0.000136	CbGpPWpGaD
Amsacrine—Body temperature increased—Doxorubicin—hematologic cancer	7.7e-06	5.53e-05	CcSEcCtD
Amsacrine—Abdominal pain—Doxorubicin—hematologic cancer	7.7e-06	5.53e-05	CcSEcCtD
Amsacrine—Diarrhoea—Methotrexate—hematologic cancer	7.69e-06	5.52e-05	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—CCND1—hematologic cancer	7.66e-06	0.000136	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	7.65e-06	0.000136	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	7.59e-06	0.000134	CbGpPWpGaD
Amsacrine—Asthenia—Epirubicin—hematologic cancer	7.55e-06	5.42e-05	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	7.52e-06	0.000133	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	7.5e-06	0.000133	CbGpPWpGaD
Amsacrine—Dizziness—Methotrexate—hematologic cancer	7.43e-06	5.34e-05	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—CDKN1A—hematologic cancer	7.41e-06	0.000131	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HDC—hematologic cancer	7.41e-06	0.000131	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTEN—hematologic cancer	7.25e-06	0.000128	CbGpPWpGaD
Amsacrine—Diarrhoea—Epirubicin—hematologic cancer	7.2e-06	5.17e-05	CcSEcCtD
Amsacrine—ABCB1—Metabolism—CDA—hematologic cancer	7.19e-06	0.000127	CbGpPWpGaD
Amsacrine—Hypersensitivity—Doxorubicin—hematologic cancer	7.17e-06	5.15e-05	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	7.15e-06	0.000127	CbGpPWpGaD
Amsacrine—Vomiting—Methotrexate—hematologic cancer	7.15e-06	5.13e-05	CcSEcCtD
Amsacrine—Rash—Methotrexate—hematologic cancer	7.09e-06	5.09e-05	CcSEcCtD
Amsacrine—Dermatitis—Methotrexate—hematologic cancer	7.08e-06	5.08e-05	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MAPK3—hematologic cancer	7.07e-06	0.000125	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—EP300—hematologic cancer	7.05e-06	0.000125	CbGpPWpGaD
Amsacrine—Headache—Methotrexate—hematologic cancer	7.04e-06	5.06e-05	CcSEcCtD
Amsacrine—Asthenia—Doxorubicin—hematologic cancer	6.98e-06	5.01e-05	CcSEcCtD
Amsacrine—TOP2A—Methyltestosterone—Prednisone—hematologic cancer	6.98e-06	0.00267	CbGdCrCtD
Amsacrine—Dizziness—Epirubicin—hematologic cancer	6.96e-06	5e-05	CcSEcCtD
Amsacrine—ABCB1—Metabolism—PC—hematologic cancer	6.92e-06	0.000123	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—EP300—hematologic cancer	6.91e-06	0.000122	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MYC—hematologic cancer	6.87e-06	0.000122	CbGpPWpGaD
Amsacrine—TOP2A—Methyltestosterone—Prednisolone—hematologic cancer	6.81e-06	0.0026	CbGdCrCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	6.79e-06	0.00012	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CDA—hematologic cancer	6.78e-06	0.00012	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	6.69e-06	0.000118	CbGpPWpGaD
Amsacrine—Vomiting—Epirubicin—hematologic cancer	6.69e-06	4.8e-05	CcSEcCtD
Amsacrine—ABCB1—Metabolism—SLC35B2—hematologic cancer	6.69e-06	0.000118	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GBA—hematologic cancer	6.69e-06	0.000118	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	6.68e-06	0.000118	CbGpPWpGaD
Amsacrine—Nausea—Methotrexate—hematologic cancer	6.68e-06	4.79e-05	CcSEcCtD
Amsacrine—Diarrhoea—Doxorubicin—hematologic cancer	6.66e-06	4.78e-05	CcSEcCtD
Amsacrine—Rash—Epirubicin—hematologic cancer	6.63e-06	4.76e-05	CcSEcCtD
Amsacrine—Dermatitis—Epirubicin—hematologic cancer	6.63e-06	4.76e-05	CcSEcCtD
Amsacrine—Headache—Epirubicin—hematologic cancer	6.59e-06	4.73e-05	CcSEcCtD
Amsacrine—CYP2D6—Metabolism—PC—hematologic cancer	6.52e-06	0.000115	CbGpPWpGaD
Amsacrine—Dizziness—Doxorubicin—hematologic cancer	6.44e-06	4.62e-05	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—MAPK3—hematologic cancer	6.32e-06	0.000112	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC35B2—hematologic cancer	6.3e-06	0.000112	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GBA—hematologic cancer	6.3e-06	0.000112	CbGpPWpGaD
Amsacrine—Nausea—Epirubicin—hematologic cancer	6.25e-06	4.49e-05	CcSEcCtD
Amsacrine—Vomiting—Doxorubicin—hematologic cancer	6.19e-06	4.44e-05	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—MYC—hematologic cancer	6.15e-06	0.000109	CbGpPWpGaD
Amsacrine—Rash—Doxorubicin—hematologic cancer	6.14e-06	4.41e-05	CcSEcCtD
Amsacrine—Dermatitis—Doxorubicin—hematologic cancer	6.13e-06	4.4e-05	CcSEcCtD
Amsacrine—ABCB1—Metabolism—MTAP—hematologic cancer	6.12e-06	0.000108	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	6.11e-06	0.000108	CbGpPWpGaD
Amsacrine—Headache—Doxorubicin—hematologic cancer	6.1e-06	4.38e-05	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	5.99e-06	0.000106	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	5.83e-06	0.000103	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	5.82e-06	0.000103	CbGpPWpGaD
Amsacrine—Nausea—Doxorubicin—hematologic cancer	5.78e-06	4.15e-05	CcSEcCtD
Amsacrine—CYP2D6—Metabolism—MTAP—hematologic cancer	5.76e-06	0.000102	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	5.64e-06	9.98e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	5.63e-06	9.96e-05	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	5.61e-06	9.93e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	5.5e-06	9.74e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—FHL2—hematologic cancer	5.45e-06	9.65e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	5.37e-06	9.5e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AGRN—hematologic cancer	5.35e-06	9.46e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	5.22e-06	9.24e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—FHL2—hematologic cancer	5.14e-06	9.09e-05	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CA—hematologic cancer	5.11e-06	9.05e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	5.08e-06	9e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—IDH2—hematologic cancer	5.07e-06	8.97e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HMMR—hematologic cancer	5.07e-06	8.97e-05	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TP53—hematologic cancer	5.05e-06	8.94e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AGRN—hematologic cancer	5.04e-06	8.92e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	4.81e-06	8.51e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HMMR—hematologic cancer	4.78e-06	8.45e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—IDH2—hematologic cancer	4.78e-06	8.45e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ARNTL—hematologic cancer	4.76e-06	8.43e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	4.68e-06	8.28e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	4.66e-06	8.26e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CA9—hematologic cancer	4.63e-06	8.2e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ACP5—hematologic cancer	4.63e-06	8.2e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NCOR2—hematologic cancer	4.57e-06	8.1e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ARNTL—hematologic cancer	4.49e-06	7.95e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CA9—hematologic cancer	4.37e-06	7.73e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ACP5—hematologic cancer	4.37e-06	7.73e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—IDH1—hematologic cancer	4.36e-06	7.71e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	4.36e-06	7.71e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	4.32e-06	7.65e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NCOR2—hematologic cancer	4.31e-06	7.63e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTO1—hematologic cancer	4.31e-06	7.63e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ABCC3—hematologic cancer	4.31e-06	7.63e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—TXN—hematologic cancer	4.31e-06	7.63e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SPHK1—hematologic cancer	4.22e-06	7.46e-05	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—AKT1—hematologic cancer	4.18e-06	7.39e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—IDH1—hematologic cancer	4.11e-06	7.27e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTO1—hematologic cancer	4.06e-06	7.19e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—TXN—hematologic cancer	4.06e-06	7.19e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ABCC3—hematologic cancer	4.06e-06	7.19e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—UGT1A1—hematologic cancer	4.05e-06	7.17e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SPHK1—hematologic cancer	3.97e-06	7.03e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	3.97e-06	7.03e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CRABP1—hematologic cancer	3.94e-06	6.98e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC22A1—hematologic cancer	3.94e-06	6.98e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALOX5—hematologic cancer	3.84e-06	6.8e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	3.84e-06	6.8e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	3.82e-06	6.76e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NUP98—hematologic cancer	3.72e-06	6.58e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	3.71e-06	6.57e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CRABP1—hematologic cancer	3.71e-06	6.57e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALOX5—hematologic cancer	3.62e-06	6.41e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ADCY7—hematologic cancer	3.61e-06	6.39e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NCOA3—hematologic cancer	3.61e-06	6.39e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NUP214—hematologic cancer	3.59e-06	6.35e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ABCG2—hematologic cancer	3.51e-06	6.22e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MTR—hematologic cancer	3.51e-06	6.22e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NUP98—hematologic cancer	3.5e-06	6.2e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ENO2—hematologic cancer	3.44e-06	6.1e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ADCY7—hematologic cancer	3.4e-06	6.02e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NCOA3—hematologic cancer	3.4e-06	6.02e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NUP214—hematologic cancer	3.38e-06	5.98e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTT1—hematologic cancer	3.34e-06	5.91e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MTR—hematologic cancer	3.31e-06	5.86e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ABCG2—hematologic cancer	3.31e-06	5.86e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SDC1—hematologic cancer	3.27e-06	5.78e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ENO2—hematologic cancer	3.25e-06	5.75e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.24e-06	5.74e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTT1—hematologic cancer	3.15e-06	5.57e-05	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.13e-06	5.54e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SDC1—hematologic cancer	3.08e-06	5.45e-05	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.93e-06	5.18e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NQO1—hematologic cancer	2.78e-06	4.92e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CD44—hematologic cancer	2.78e-06	4.92e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYCS—hematologic cancer	2.63e-06	4.65e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CD44—hematologic cancer	2.62e-06	4.63e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NQO1—hematologic cancer	2.62e-06	4.63e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.61e-06	4.62e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYCS—hematologic cancer	2.48e-06	4.38e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	2.46e-06	4.35e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTP1—hematologic cancer	2.32e-06	4.1e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.18e-06	3.86e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTM1—hematologic cancer	2.13e-06	3.77e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NCOR1—hematologic cancer	2.13e-06	3.77e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.07e-06	3.66e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.01e-06	3.55e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.01e-06	3.55e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MTHFR—hematologic cancer	1.88e-06	3.33e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.77e-06	3.14e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.58e-06	2.8e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.49e-06	2.64e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CREBBP—hematologic cancer	1.46e-06	2.59e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.39e-06	2.46e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.38e-06	2.44e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALB—hematologic cancer	1.37e-06	2.43e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.31e-06	2.32e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.31e-06	2.32e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALB—hematologic cancer	1.29e-06	2.29e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.24e-06	2.19e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.21e-06	2.14e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.14e-06	2.02e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTEN—hematologic cancer	1.05e-06	1.85e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—EP300—hematologic cancer	9.98e-07	1.77e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTEN—hematologic cancer	9.86e-07	1.75e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—EP300—hematologic cancer	9.4e-07	1.66e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CA—hematologic cancer	7.38e-07	1.31e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	6.96e-07	1.23e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AKT1—hematologic cancer	6.03e-07	1.07e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AKT1—hematologic cancer	5.68e-07	1.01e-05	CbGpPWpGaD
